Minneapolis Clinical Trials
Connect Study
Participate in a clinical study of a potential treatment for autoimmune conditions such as inflammatory bowel conditions and skin diseases
3 Stays of 4 nights
9 visits
Participate in a clinical study of a potential treatment for inflammatory conditions and skin diseases.
The goal of this study is to determine the safety and tolerability of SAR442999.
There is one screening appointment, prior to three inpatient stays each 4 nights/ 5 days and PCR covid testing
Reimbursement for study participation time and travel of up to $8,228
This study has been approved by an independent ethics committee.
Call Vanessa: 763-453-1011 or William 763-453-1075
Eligibility
Age: 18-55
BMI: 18-30kg/m2
Medications: No prescription medications allowed, able to avoid over the counter supplements for 14 days prior to dose.
Smoking Status: No more than 5 cigarettes per week or equivalent (vape users)
Compensation: Up to $8,228